| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |